Phillips Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, ...
Dry powder inhalers (DPIs) have become a mainstay in the management of chronic pulmonary diseases such as chronic obstructive pulmonary disease and asthma. Their performance depends on a complex ...
Aptar Pharma pulled the trigger on a deal for Pharmaxis’ Orbital high payload dry powder inhaler technology, paying $2.5 million for a worldwide license with the same again to follow if it chooses to ...
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has entered into an exclusive ...
Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...
Please provide your email address to receive an email when new articles are posted on . A metered-dose inhaler was switched to a dry-powder inhaler in Veterans Affairs facilities. Veterans who did vs.
Hosted on MSN
Finding the right asthma inhaler for you
New triple therapy: The FDA approved AstraZeneca’s Breztri Aerosphere for asthma patients 12 and older, offering a single inhaler combining ICS/LABA with a LAMA for maintenance treatment. Device ...
multiple inhalers on a white background Researchers explored the association between dry powder inhaler technique errors and exacerbations and health status in patients with COPD. Severe COPD ...
When it comes to inhalers for respiratory diseases, we’re not just talking about puffing your way to easier breathing; apparently, we’re also blowing up the planet with greenhouse gases. The device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results